Emerging Markets Earnings Roundup: Pfizer (Part 4)
This article was originally published in PharmAsia News
Executive Summary
Pfizer considers the structure of its pharma operations in emerging markets as the dust begins to settle from its spin-off of its animal health business and the sale of its nutrition business.